BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26159230)

  • 21. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.
    Castriconi R; Dondero A; Negri F; Bellora F; Nozza P; Carnemolla B; Raso A; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2007 Nov; 37(11):3190-6. PubMed ID: 17918205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional self-organizing neural architectures: a neural stem cells reservoir and a system for neurodevelopmental studies.
    Cristini S; Alessandri G; Acerbi F; Ciusani E; Colombo A; Fascio U; Nicosia RF; Invernizzi RW; Gelati M; Parati EA; Invernici G
    Tissue Eng Part C Methods; 2011 Nov; 17(11):1109-20. PubMed ID: 21721991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.
    da Cunha Jaeger M; Ghisleni EC; Cardoso PS; Siniglaglia M; Falcon T; Brunetto AT; Brunetto AL; de Farias CB; Taylor MD; Nör C; Ramaswamy V; Roesler R
    J Mol Neurosci; 2020 Jun; 70(6):981-992. PubMed ID: 32056089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.
    Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM
    Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.
    Tang X; Yao Y; Zhu J; Jin K; Wang Y; Mao Y; Zhou L
    Childs Nerv Syst; 2012 Nov; 28(11):1869-77. PubMed ID: 22814953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
    Fan X; Matsui W; Khaki L; Stearns D; Chun J; Li YM; Eberhart CG
    Cancer Res; 2006 Aug; 66(15):7445-52. PubMed ID: 16885340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
    Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical activity of the liposomal cisplatin lipoplatin in ovarian cancer.
    Casagrande N; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Clin Cancer Res; 2014 Nov; 20(21):5496-506. PubMed ID: 25231401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective adenovirus-mediated gene transfer into neural stem cells derived from human embryonic stem cells.
    Bertram CM; Hawes SM; Egli S; Peh SL; Dottori M; Kees UR; Dallas PB
    Stem Cells Dev; 2010 Apr; 19(4):569-78. PubMed ID: 19594361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytes influence medulloblastoma phenotypes and CD133 surface expression.
    Gronseth E; Gupta A; Koceja C; Kumar S; Kutty RG; Rarick K; Wang L; Ramchandran R
    PLoS One; 2020; 15(7):e0235852. PubMed ID: 32628717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
    Cox JL; Wilder PJ; Desler M; Rizzino A
    PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
    Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
    Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133 expression by neural progenitors derived from human embryonic stem cells and its use for their prospective isolation.
    Peh GS; Lang RJ; Pera MF; Hawes SM
    Stem Cells Dev; 2009 Mar; 18(2):269-82. PubMed ID: 18651819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia promotes stem-like properties of laryngeal cancer cell lines by increasing the CD133+ stem cell fraction.
    Wu CP; Du HD; Gong HL; Li DW; Tao L; Tian J; Zhou L
    Int J Oncol; 2014 May; 44(5):1652-60. PubMed ID: 24573690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.
    Lim KJ; Bisht S; Bar EE; Maitra A; Eberhart CG
    Cancer Biol Ther; 2011 Mar; 11(5):464-73. PubMed ID: 21193839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.